Laura Gibson is an associate professor of medicine and of pediatrics at UMass Chan Medical School. CMV belongs to the same virus family as cold sores and chickenpox and, like those viruses, lives in ...
Credit: Getty Images This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of CMV infection in solid organ transplant recipients.
Human cytomegalovirus infections are still associated with severe morbidity and mortality in immunocompromised individuals, despite the availability of five drugs that are currently licensed for ...
Cytomegalovirus (CMV) is a ubiquitous herpesvirus that, while often latent in the general population, can become reactivated in individuals with compromised immune systems. Inflammatory bowel disease ...
Health experts say CMV infection after transplant can lead to severe illness, prolonged hospitalisation, organ damage, and ...
In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital (BWH) has ...
Cytomegalovirus (CMV) is a ubiquitous member of the Herpesviridae family that can establish latent infections in humans but may reactivate to cause disease in both immunocompromised and, increasingly, ...
VANCOUVER, British Columbia—Cytomegalovirus (CMV) infection in kidney or kidney/pancreas transplant recipients occurs more frequently when alemtuzumab is used for induction instead of antithymocyte ...
Babies born with a cytomegalovirus (CMV) infection or congenital cytomegalovirus can be at higher risk for serious complications. Congenital CMV is the leading cause of non-genetic hearing loss and ...
NEW ORLEANS — Maribavir, an antiviral once deemed promising for cytomegalovirus (CMV) infection but discarded after a negative phase 3 trial, has been shown to be effective in treatment-resistant and ...
—These investigators explored associations among early-life and in utero infections and cytomegalovirus-positive acute lymphoblastic leukemia in children, with signs pointing to underlying immune ...
Moderna, Inc. (NASDAQ:MRNA) revealed topline results on Wednesday from a Phase 3 trial evaluating the efficacy of mRNA-1647, the company’s investigational cytomegalovirus (CMV) vaccine. CMV is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results